Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2005.339 | An Open-Label, Phase II Trial of Patupilone (EPO906) as Monotherapy to Evaluate Activity of Patupilone in Patients with Advanced Unresectable and/ or Metastatic Hepatocellular Carcinoma (HCC) | Prof. Mok S.K. Tony |
| 2005.338 | A Phase I, Multi-Centre, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Local and Systemic Tolerability of the Therapeutic DNA Plasmid PDPSC18 Vaccine Administered by Particle Mediated Epidermal Delivery Using the Powderject ND10 Delivery System in Subjects with Chronic Hepatitis B Infection | Dr. Leung Wai Yee Nancy |
| 2005.337 | A Randomized, Double-Blind, Multiple-Dose Escalation Study of the Effect of Danggui Buxue Tang ( | Prof. Christopher John Haines |
| 2005.336 | The Efficacy of Nitric Oxide in Stroke (ENOS) Trial A prospective, collaborative, international, multicentre, randomised, parallel-group, single and outcome blinded, controlled, factorial trial to investigate the safety and efficacy of treatment with transdermal glyceryl trinitrate, A nitric oxide donor, and of stopping or continuing prior antihypertensive therapy, in patients with acute stroke | Prof. Wong Ka Sing Lawrence |
| 2005.333 | Comparison of Nifedipine GITS with Nifedipine Slow Release in Essential Hypertension | Prof. Brian Tomlinson |
| 2005.332 | Randomized Trial Comparing Alfuzosin GITS 10mg Daily With Placebo For Trial Without Catheter In Acute Urinary Retention With Long Term Follow UP | Dr. Cheng Chi Wai |
| 2005.330 | Effect of Levetiracetam On Quality of Life in Patients with Uncontrolled Epilepsy Trial (ElLOQUENT) | Dr. Kwan Patrick |
| 2005.327 | Long-Term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822 | Prof. Li Kwok Ming Edmund |
| 2005.325 | External Radiotherapy for Unresectable Hepatocellular Carcinoma Under Respiratory Gating-Phase I/II Study | Prof. Mok S.K. Tony |
| 2005.324 | Right Thoracic Paravertebral Analgesia for Percutaneous Radiofrequency Ablation of Liver Tumors | Dr. Cheung Ning Michelle |
| 2005.318 | Clinical Evaluation of the Safety and Performance of the Penumbra | Prof. YU Simon Chun Ho |
| 2005.317 | Clinical Trial on Herbal Treatment of Primary Insomnia | Prof. Wing Yun Kwok |
| 2005.313 | Randomized Trial Comparing Terazosin 5mg Daily and Doxazosin GITS 4mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up | Dr. Cheng Chi Wai |
| 2005.310 | The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia of Chinese Patients | Dr. Ng Chi Fai |
| 2005.309 | Clinical Bioequivalence Study on Two Aspirin Formulations | Prof. Chow S.S. Moses |
| 2005.308 | Clinical Bioequivalence Study on Two Fluoxetin Formulations | Prof. Yin Qiping Ophelia |
| 2005.307 | Can Targeted Elimination of B-Cell Depletion Therapy and/or Combination Therapy Restore Peripheral B Cell Abnormalities in Systemic Lupus Erythematosus (SLE) ? | Prof. Li Kwok Ming Edmund |
| 2005.304 | Fluid Accumulation Status Trial (FAST) | Prof. Yu Cheuk Man |
| 2005.303 | A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects with Complicated Intra-Abdominal Infection | Prof. Lai Bo Shan Paul |
| 2005.302 | Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study to Compare Celecoxib (200mg BID) with Diclofenac SR (75mg BID) Plus Omeprazole (20mg QD) for Gastrointestinal Events in Subjects with Osteoarthritis and Rheumatoid Arthritis at High-Risk of Gastrointestinal Adverse Events | Prof. Chan Ka Leung Francis |
| 2005.301 | Desmoteplase (INN) in Acute Ischemic Stroke: Phase III, DIAS-2 A Prospective, Randomized, Double-blind, Placebo-Controlled,,Single Bolus, Multinational, Multi-center, Parallel Group, Dose Ranging Study of Desmoteplase (INN) in the Indication of Acute Stroke | Prof. Wong KS Lawrence |
| 2005.300 | An Open-Label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80mg + Hydrochlorothiazide 25mg tablets Alone or in Combination with Other Antihypertensive Medications in Patients with Hypertension | Prof. Kong Pik Shan Alice |
| 2005.299 | A Prospective Randomized Study to Compare a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 25mg With a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg in Patients with Uncontrolled Hypertension Who Fail to Respond Adequately to Treatment with a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg | Prof. Kong Pik Shan Alice |
| 2005.297 | The Effect of Sulodexide in Overt Type 2 Diabetic Nephropathy | Prof. Chan Juliana |
| 2005.296 | The Effect of Sulodexide in Patients with Type 2 Diabetes and Microalbuminuria | Prof. Tong CY Peter |
| 2005.288 | A Phase I/II Study of PXD101 in Patients with Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation | Prof. Yeo Winnie |
| 2005.287 | A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study of Esomeprazole I.v. (Bolus Infusion of 80mg Followed by a Continuous Infusion of 8mg per hour) Administered for 72 hours to Assess Prevention of Rebleeding in Subjects that Have Undergone Successful Primary Endoscopic Haemostasis of A Bleeding Peptic Ulcer ・the PUB Study | Prof. Sung Joseph |
| 2005.286 | (EARLY: Endothelin Antagonist Trial in Mildly Symptomatic PAH Patients) A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients with Mildly Symptomatic Pulmonary Arterial Hypertension | Prof. Li Kwok Ming Edmund |
| 2005.281 | Hong Kong Optimal Pacing to Preserve Left Ventricular Function Study | Dr. Fung Wing Hong |
| 2005.279 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Indenix-Sponsored Telbivudine Studies | Prof. Chan Lik Yuen Henry |
| 2005.275 | A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From any Cause in Patients with Atrial Fibrillation / Atrial Flutter (AF / AFL) | Prof. Yu Cheuk Man |
| 2005.274 | Use of LigaSure Vessel Sealing System in Prevention of Seroma in Laparoscopic Totally Extraperitoneal Hernioplasty: A Randomized Controlled Trial | Dr. Hon Sok Fei |
| 2005.272 | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects (SB-767905/008) | Prof. Gin Tony |
| 2005.267 | A Randomized Comparative Study of the Safety and Efficacy of Different Dosages of Intravitreal Dexamethasone in the Treatment of Clinically Significant Diabetic Macular Edema (CSME) | Prof. Lam S.C. Dennis |
| 2005.257 | A 2-Year Study to Assess the Efficacy, Safety, and Tolerability of Taranabant in Obese Patients Followed by a 1-Year Extension | Dr. Chow Chun Chung Francis |
| 2005.255 | A Long-Term, Post Treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies G-PLUS (GALLANT, GALLEX and ARMOR | Prof. Chan C.N. Juliana |
| 2005.254 | A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients with Type 2 Diabetes Mellitus (GALLEX 4) | Prof. Chan C.N. Juliana |
| 2005.253 | A Randomized, Double-blind, Placebo-Controlled, Multicentre Phase 3 Study to Evaluate the Long-term Safety of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain | Prof. Gin Tony |
| 2005.250 | Premedication with Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-Controlled Trial | Dr. Liu Yuk Wah Shirley |
| 2005.249 | A Randomized Controlled Trial to Compare the Safety and Efficacy of Grid Laser Versus Posterior Subtenon Triamcinolone Versus Combined Subtenon Triamcinolone and Grid Laser in the Treatment of Clinically Significant Diabetic Macular Edema | Prof. Lam S.C. Dennis |
| 2005.248 | A Randomized, Open Label Study Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS_) or Adefovir Dipivoxil (ADV) in Patients with Lamivudine Resistant HBeAg Positive Chronic Hepatitis B | Prof. Sung JY Joseph |
| 2005.246 | The Use of Intravenous Ondansetron (Zofran_) to Relieve Postoperative Nausea and Vomiting after Intragastric Balloon Placement: A Randomized Controlled Trial | Dr. Mui Lik Man Wilfred |
| 2005.245 | A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin | Prof. Chan T.C. Anthony |
| 2005.231 | Study of Pharmacogenetics, Pharmacodynamics and Population Pharmacokinetics of Rosuvastatin in Chinese Patients with Hyperlipidaemia | Prof. Brian Tomlinson |
| 2005.230 | Sensitivity of the InSync | Prof. Yu Cheuk Man |
| 2005.229 | A Phase I, Dose Escalation Trial of Recombinant Modified Vaccinia Ankara (MVA)-based Vaccine Encoding Epstein-Barr Virus Target Antigens | Prof. Chan T.C. Anthony |
| 2005.228 | A Triple-Blinded, Randomized, Placebo-Controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients with Parkinson | Dr. Yeung Hon Ming Jonas |
| 2005.224 | Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale | Prof. Lee T.S. Dominic |
| 2005.216 | A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-week Study Evaluating the Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20mg and 40mg Alone or in Combination with 12.5 mg to 25 mg of Hydrochlorothiazide in Subjects with Mild to Moderate Essential Hypertension | Prof. Lee Albert |
| 2005.212 | A Multicenter, Double-Blind, Randomized, Placebo Controlled Study on the Effect of Ultra-Low Dose Transdermal Estradiol (Menostar_ 0.014 mg/day via weekly patch) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-Being in Postmenopausal Asian Women Over 12 Weeks | Prof. Christopher John Haines |
Page 244 of 254.